Search articles in Pharma Appointments
Filter Articles
Sections
- All (3,079 articles)
- Pharma Events (45 articles)
- For Recruiters (233 articles)
- Careers Events (5 articles)
- Partners (3 articles)
-
News
(2,565 articles)
- Industry Features (106 articles)
- Pharma Appointments (1,274 articles)
- COVID-19 (106 articles)
- Pharmaceuticals (653 articles)
- Biotechnology (139 articles)
- Clinical Research (221 articles)
- Artificial Intelligence (49 articles)
- Medical Devices (15 articles)
- Healthcare (21 articles)
- R & D (30 articles)
- Regulatory Affairs (43 articles)
- HR / Recruitment (5 articles)
- Sales / Commercial (10 articles)
- Manufacturing (2 articles)
- Medical Communications (2 articles)
- Careers Advice (261 articles)
- Company Focus (109 articles)
- Company Career Hubs (1 article)
- Pharma Training (6 articles)
- 25 Years of PharmiWeb (13 articles)
- DE&I (1 article)
Found 1,274 articles
Greenphire Adds Industry Veteran Dan Shannon as New Chief Experience Officer
- 29 Feb 2024
Greenphire, a leading innovator in software solutions for improving clinical research site performance and participant satisfaction, today announced the addition of healthcare technology executive Dan Shannon as its new Chief Experience Officer (CXO). As CXO, he will oversee service delivery and steward the journey of continuous evolution toward an optimal client experience from beginning to end.
Curia Appoints Steve Lavezoli as Vice President, Biologics
- 28 Feb 2024
Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.
Kalderos Attracts Two Recognized Industry Leaders to Board of Directors
- 27 Feb 2024
Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the addition of two experienced and highly respected industry veterans to its board of directors.
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
- 21 Feb 2024
AbbVie (NYSE: ABBV) today announced that its board of directors has unanimously selected Robert A. Michael, AbbVie's current president and chief operating officer, to succeed Richard A. Gonzalez as the company's chief executive officer (CEO).
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
- 20 Feb 2024
Opthea Limited (ASX:OPT; NASDAQ:OPT, “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced the appointment of Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor.
-
Justin Hely to be appointed as Chief Executive Officer of GenesisCare U.K. and Europe
- 12 Feb 2024
GenesisCare, the UK’s leading private provider of cancer care, today announced the appointment of Justin Hely, MBA, as GenesisCare Chief Executive Officer of the UK and Europe.
Zymeworks Announces Appointment Of Dr. Alessandra Cesano To Its Board Of Directors
- 9 Feb 2024
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Alessandra Cesano to its board of directors effective February 8, 2024.
BioPartner UK Appoints Strategic Communications Specialist Dr Priya Kalia to Advisory Board
- 7 Feb 2024
Communications specialist and entrepreneur to help promote expansion of UK-based life sciences trade association focused on growing partnerships
Dianne Hol appointed new Executive Vice President People & Organization at Lundbeck
- 5 Feb 2024
H. Lundbeck A/S (Lundbeck) today announced the appointment of Dianne Hol to the role of EVP, People & Organization. Dianne will join Lundbeck on 1 April 2024 and will be part of the Executive Management.
Dr Paul Wicks joins precision medicine startup Sano Genetics as VP of Neuroscience
- 5 Feb 2024
Dr Paul Wicks, a neuropsychologist who has worked in the field of ALS (also known as MND) research for 22 years, joins the ranks of precision medicine scaleup Sano Genetics today, where he will take up the full-time role of Vice President of Neuroscience.
EMS Healthcare appoints Dr Clare Grace as Chief Executive Officer
- 5 Feb 2024
EMS Healthcare, a leading provider of flexible medical and clinical research facilities, today announced the appointment of Dr Clare Grace as Chief Executive Officer. Dr Grace joins Cheshire-based EMS Healthcare on the 1st February 2024 from PAREXEL International, where she served as Chief Patient Officer.
BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer
- 5 Feb 2024
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today announces the appointment of Dr. Joerg Moeller as Chief Executive Officer and Executive Board member with immediate effect.
SPT Labtech Appoints New Chief Commercial Officer
- 2 Feb 2024
SPT Labtech is pleased to announce the appointment of Morten Frost Norgreen as Chief Commercial Officer (CCO) as of February 1st, 2024.
Cytel Appoints Jovan Willford as Chief Executive Officer
- 2 Feb 2024
Cytel Inc., a leading provider of innovative statistics and health data analytics to the life sciences industry, today announced that Jovan Willford, a dynamic leader known for transformation, growth and a customer-centric approach, has been named Chief Executive Officer and member of its Board of Directors effective immediately.
Parexel Appoints Susan R. Salka to Board of Directors
- 2 Feb 2024
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the appointment of Susan R. Salka, retired Chief Executive Officer and President of AMN Healthcare Services, Inc., to its Board of Directors. Ms. Salka’s appointment is effective Feb. 1.
Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO
- 1 Feb 2024
Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced today that Dr Arndt Schottelius has been appointed as the new Chief Executive Officer, effective on 1 March 2024, to take the Company to its next phase of development.
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board
- 31 Jan 2024
Lindus Health, an anti-CRO running radically faster, more reliable clinical trials for life science pioneers, has announced the appointment of Professor Robert S. Langer, renowned scientist, Institute Professor at Massachusetts Institute of Technology (MIT), and co-founder of Moderna, Inc. to its Advisory Board.
Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman
- 31 Jan 2024
Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate update, highlighting significant milestones and developments that have shaped Huxley over the past year.
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
- 25 Jan 2024
Lindus Health, an anti-CRO running radically faster, more reliable clinical trials for life science pioneers, is announcing the appointment of Professor Robert S. Langer, renowned scientist, Institute Professor at Massachusetts Institute of Technology (MIT), and co-founder of Moderna, Inc. to its Advisory Board.